Drugmaker AstraZeneca said it intends to cap out-of-pocket prices of four medicines used to treat asthma and chronic obstructive pulmonary disease (COPD) to $35 per month for many patients.

Poor treatment of asthma and COPD puts a huge burden on the NHS. For example, £1 billion is spent on asthma treatment in the UK each year and represents 60,000 to 65,000 hospital admissions.

Many similarities exist between COPD and asthma, including symptoms including breathing difficulties and restricted airways. COPD is progressive and persistent, though. Allergens can aggravate asthma ...

The Spanish COPD guidelines recommend treatment of the mixed COPD–asthma phenotype with ICS and a long-acting bronchodilator (LABD) as a first option to improve lung function, respiratory ...

Background: For several years, asthma and COPD have been regarded as distinct entities, with distinct clinical courses. However, despite distinctive physiologic features at the time of diagnosis ...

This roundup offers a look at the latest insights from the clinicians and researchers investigating chronic obstructive pulmonary disease and asthma.

The research showed that that between October – November 2022, an average of 258,202 people were dispensed medication licensed for asthma and/or COPD in Ireland. Within that group, almost 1 in 5 ...

Tessa Romero, an analyst from J.P. Morgan, has initiated a new Buy rating on Upstream Bio, Inc. (UPB). Tessa Romero’s rating is based on ...

GP practices across Greater Manchester will be testing software designed to improve asthma and COPD care during annual reviews. Over two years 150 practices will be testing the LungHealth software ...